Stock Updates

Today’s Top Gainers in the Market Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) from Healthcare

Today’s top gainers include the company Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) which is in the industry Biotechnology, gaining 1.31% today. In the last week its performance is -3.76%, and -3.42% for the past quarter. Currently, Regeneron Pharmaceuticals, Inc., REGN has a target price of 467.73, so today’s gain of 1.31% is a significant step towards its target price. The GAP today is therefore -0.08%.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), has a market cap of 39553.08, and is based in USA. Insider ownership is at 0.50%, and institutional ownership is 71.20%.

At the current price of 371.53, it has a dividend yield of *TBA, and its target price is 467.73. This is with a profit margin of 16.00%, and total debt/equity of 0.09. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has a P/E of 58, as well as a forward P/E of 25.53.

With a current EPS of 6.41, and a forecasted EPS growth for next year at 32.33%,Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has had a EPS growth for the past five years at 44.90%. For the next five years EPS growth is projected to be 18.62%.

Performance for the year is -29.04%. Since its IPO date on 4/2/1991, the total performance to date is -31.56%.

Volume today for Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), is 413400, while its average volume is 726.97. Whilst the total gain today was 1.31%, it did have a day high of -13.41%.

Volatility for this week has been at 2.70%, and 2.60% for the month. The 52-week low for Regeneron Pharmaceuticals, Inc., REGN has been 12.90%, while the 52-week-high has reached -37.30%.

Looking at its return of investments, which is 16.00%, and its return on assets is 13.00%. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has an operating margin of 26.70%. With a sales growth of 21.40% quarter over quarter. Bearing in mind that Regeneron Pharmaceuticals, Inc., REGN is in the sector Healthcare, its long-term debt/equity is 0.09, and has a current ratio of 3.4 and 3.1 for quick ratio.

So what is the value of Regeneron Pharmaceuticals, Inc.? Well its PEG is 3.11, and the P/S is 8.51, along with a P/B of 9.54. Meanwhile it has a p/cash of 37.84.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment